Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor

Journal of Neuroscience

Volumn 21, Issue 14, 2001, Pages 5239-5250

  Miyakawa, Tsuyoshi ^a   Yamada, Masahisa ^b   Duttaroy, Alokesh ^b   Wess, Jürgen ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Acetylcholine; Behavioral phenotyping; Gene targeting; Hyperactivity; Knock out; Learning; M1 receptor; Muscarinic receptor

Indexed keywords

ACETYLCHOLINE; CHOLINERGIC RECEPTOR; MUSCARINIC M1 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; FOREBRAIN; GENE TARGETING; HIPPOCAMPUS; HYPERACTIVITY; LEARNING; LOCOMOTION; MALE; MOTOR COORDINATION; MOUSE; NOCICEPTION; NONHUMAN; PHENOTYPE; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REFLEX; SWIMMING; TASK PERFORMANCE;

EID: 0035879062     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-14-05239.2001     Document Type: Article

References (65)

1. Scopolamine selectively disrupts the acquisition of contextual fear conditioning in rats
2. Scopolamine and Pavlovian fear conditioning in rats: Dose-effect analysis
3. Role of muscarinic receptor subtypes in central antinociception
4. Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes
5. Muscarinic receptor agonists and antagonists
6. Localization of a family of muscarinic receptor mRNAs in rat brain
7. Potential role of muscarinic receptors in schizophrenia
8. Muscarinic receptors: Characterization, coupling and function
9. 1 receptors in the nucleus accumbens mediate behavioral depression. A possible downstream target for fluoxetine
10. Alzheimer's disease: A disorder of cortical cholinergic innervation
11. What's wrong with my mouse? Behavioral phenotyping of transgenic and knockout mice
12. Early development of muscarinic supersensitivity in a genetic animal model of depression
13. Anticholinergic effects on acquisition of place learning in the Morris water task: Spatial mapping deficit or inability to inhibit nonplace strategies?
14. Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions
15. Antagonist binding profiles of five cloned human muscarinic receptor subtypes
16. Effects of scopolamine, pentobarbital, and amphetamine on radial arm maze performance in the rat
17. Antimuscarinic drugs in the treatment of movement disorders
18. The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs
19. Endogenous acetylcholine in the dorsal hippocampus reduces anxiety through actions on nicotinic and muscarinic 1 receptors
20. 1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update
21. 1 muscarinic receptor antagonist dicyclomine on emotional memory
22. 1 receptors induce transient anterograde amnesia in mice
23. 1 receptors
24. 2 muscarinic acetylcholine receptor knockout mice
25. 4 muscarinic acetylcholine receptor knockout mice
26. Lack of task specificity and absence of posttraining effects of atropine on learning
27. 1 muscarinic antagonist pirenzepine
28. 1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice
29. 4 muscarinic receptor proteins in the rat striatum: Light and electron microscopic immunocytochemistry using subtypespecific antibodies
30. Brain neurotransmitter changes in Parkinson's disease
31. Behavioural evaluation of cholinergic drugs
32. Is cholinergic sensitivity a genetic marker for the affective disorders?
33. Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function
34. 5 muscarinic acetylcholine receptors in peripheral tissues and brain
35. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies
36. 4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation
37. Radial maze performance, open-field and elevated plus-maze behaviors in Fyn-kinase deficient mice: Further evidence for increased fearfulness
38. Neurogranin null mutant mice display performance deficits on spatial learning tasks with anxiety related components
39. The effect of chronic atropine administration on mouse motility and on ACh levels in the central nervous system
40. Scopolamine impairs performance of a place and cue task in rats
41. Selective breeding for increased cholinergic function: Development of a new animal model of depression
42. Selective breeding for diisopropyl fluorophosphate-sensitivity: Behavioural effects of cholinergic agonists and antagonists
43. Potential animal model of multiple chemical sensitivity with cholinergic supersensitivity
44. Attention deficit/hyperactivity disorder: Characteristics, interventions and models
45. Cholinergic receptor blockade can impair the rat's performance on both the place learning and cued versions of the Morris water task: The role of age and pool wall brightness
46. Behavioral despair in mice: A primary screening test for antidepressants
47. Muscarinic receptor subtypes in human neurodegenerative disorders: Focus on Alzheimer's disease
48. 1 muscarinic receptor antagonists disrupt memory consolidation of inhibitory avoidance in rats
49. Scopolamine administered before and after training impairs both contextual and auditory-cue fear conditioning
50. Detailed behavioral analysis of water maze acquisition under systemic NMDA or muscarinic antagonism: Nonspatial pretraining eliminates spatial learning deficits
51. A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice
52. Dose-response curves and time-course effects of selected anticholinergics on locomotor activity in rats
53. Muscarinic antagonists are anxiogenic in rats tested in the black-white box
54. Treatment of central nervous system degenerative disorders
55. Cholinergic receptor blockade impairs spatial localization by use of distal cues in the rat
56. Effects of scopolamine on extracellular acetylcholine and choline levels and on spontaneous motor activity in freely moving rats measured by brain dialysis
57. Characterization of the effects of scopolamine on the habituation of exploratory activity: Differential effects of oxotremorine and physostigmine
58. Near-total loss of "learning" and "memory" as a result of combined cholinergic and serotonergic blockade in the rat
59. Advances and limitations of the molecular neuroanatomy of cholinergic receptors: The example of multiple muscarinic receptors
60. Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia
61. Molecular biology of muscarinic acetylcholine receptors
62. Cholinergic receptors
63. Cholinergic receptor blockade produces impairments in a sensorimotor subsystem for place navigation in the rat: Evidence from sensory, motor, and acquisition tests in a swimming pool
64. Disruption of central cholinergic systems in the rat by basal forebrain lesions or atropine: Effects on feeding, sensorimotor behaviour, locomotor activity and spatial navigation
65. 3 muscarinic acetylcholine receptor are hypophagic and lean